A New Tool for Helping Labs Improve Diversity in Clinical Trials
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
After peaking in the first quarter of 2021, with 42 SPACs raising a total of $11 billion, the blank-check company craze has fallen off significantly.
Last week, CMS announced that it was eliminating certain waivers and regulatory flexibility it provided when the COVID-19 pandemic began.
While labs...
The kinder, gentler version of the standard removes key controversial elements, such as mandating vaccination for employees.
The model, meant to start Jan. 1 of this year, had already been delayed over concerns from key stakeholders, and its start date is now TBD
Key stakeholders hold a briefing to inform lawmakers of the impact of potential new regulations for laboratory developed testing procedures.
The White House recently provided on update on agencies’ progress in carrying out EO to boost Medicaid and the Affordable Care Act
On Feb. 23, the...
Webinar will give you the chance to learn about recent changes at G2 and ask the editorial team any questions you may have.